Allogene Therapeutics develops AlloCAR T™ products, utilizing multiplex gene-engineering and proprietary lymphodepletion techniques to create allogeneic CAR T therapies for blood cancers and autoimmune diseases. Their approach addresses the limitations of autologous CAR T therapies by enabling scalable, off-the-shelf treatments that can serve over 100 patients from a single manufacturing run.

ByHeart produces an FDA-registered infant formula featuring a patented protein blend that closely mimics the composition of breast milk, utilizing organic, grass-fed whole milk for enhanced nutrient absorption and easier digestion. The formula addresses common infant feeding challenges by promoting softer stools, reduced spit-up, and improved weight gain, all backed by clinical research.

Candid Therapeutics develops targeted therapies for autoimmune diseases, focusing on novel mechanisms of action. Their pipeline includes candidates designed to modulate immune pathways and improve patient outcomes. The company aims to address unmet clinical needs with scientifically validated drug candidates.

Community is a conversational platform that utilizes SMS technology to enhance audience engagement and build genuine relationships through direct messaging. It addresses communication challenges by enabling brands to capture insights and drive action, resulting in significantly higher engagement rates compared to traditional social media channels.

Hubble offers a subscription service for contact lenses and eyewear, providing premium silicone hydrogel lenses for daily and monthly wear, along with prescription eyeglasses starting at $49.99. This service addresses the inconvenience of purchasing vision correction products by delivering customized lenses and eyewear directly to customers' homes, ensuring affordability and ease of access.

Kronos Bio develops therapies that target dysregulated transcription factors within their transcriptional regulatory networks to treat hard-to-reach cancers and autoimmune diseases. Their pipeline includes molecules like Istisociclib, a CDK9 inhibitor for MYC-dependent tumors, and KB-9558, which targets the KAT domain of p300 in multiple myeloma and HPV-driven tumors.

Light is a financial platform that automates general ledger management, accounts receivable, and accounts payable processes for multinational companies using AI-driven analytics and real-time reporting. This solution addresses the complexities of financial operations by streamlining compliance and enhancing efficiency across diverse currencies and regulatory environments.

Neogene Therapeutics develops engineered T cell receptor therapies that specifically target neo-antigens, which are mutated proteins found in solid tumors. This approach aims to enhance the immune response in cancer patients, providing a personalized treatment option for those with difficult-to-treat cancers.

Plum Life offers a fully digital platform for agents and advisors to sell life insurance policies, featuring a streamlined application process and transparent case management tools. This solution addresses the need for efficient online transactions while providing clients with access to a diverse range of competitively priced insurance products.

Revi is a conversational marketing platform utilizing artificial intelligence to enhance customer engagement specifically for e-commerce businesses. It centralizes WhatsApp campaigns, behavioral data analysis, and team support into a single solution for managing the entire customer journey. The platform enables personalized campaign automation, real-time performance tracking, and intelligent customer relationship management to drive sales and recurring revenue.

Rilla provides virtual ridealong software that enables outside sales representatives and technicians to record customer interactions using its app, which employs AI for automatic transcription and analysis. This technology enhances sales performance by delivering actionable feedback and allows sales managers to conduct virtual ridealongs more efficiently than traditional methods.